Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
From infection until patient recovery during a viral infection, both innate and adaptive immune cells play an important role.
Extensive flow cytometry–based characterization of immune cell subsets during viral disease pathogenesis has been done during the previous CoV infection (as reviewed in Prompetchara E. et al. 2020). Currently, very limited information is available on the host innate immune status of SARS‐CoV‐2‐infected patients (Cossarizza A. et al. 2020).
Deep characterization of immune cells to monitor disease pathogenesis as well as efficacy of antiviral therapy is crucial. Miltenyi Biotec provides the largest recombinant antibody portfolio for flow cytometry–based characterization of immune cells.
Several recent articles (PMID: 32203188; 32203186) have described multicolor flow cytometry analysis to characterize immune repertoire during the course of a COVID 19 infection. The most commonly used markers are listed below.
Using REAfinity™ Recombinant Antibodies can enhance reproducibility and standardization of your immunophenotyping.
Immunophenotyping category | Specific markers | ||||
---|---|---|---|---|---|
Cell subset | T cell | B cell | NK cell | Antigen presenting cell (DC, monocytes) | |
CD3, CD4, CD8, CD27 | CD19, CD20, IgA, IgM, | CD56, CD16 | CD14, CD11c, CD16 | ||
Naïve and memory marker | CD45RA, CD45RO, CD62L | ||||
Transcription factor | Tbet, FoxP3, RORγt, Stat1, Stat5 , Stat6, IRF4, TOX | ||||
Intracellular cytokine | IFNγ, TNFα IL2, IL-17A, IL-17F, IL-10, TGF-b, IL-6, IL-12, IL-21, GM-CSF | ||||
Activation/Exhaustion marker | CD25, CD69, CD38, HLA-DR, PD-1, CD28, CD57, CCR7, CD127, CD95, CD107a, 41BB, CD40L, CTLA-4, TIGIT, TIM3, LAG3, NKG2A, KLRG1, CD137, CD86, CD80, CD244 (2B4) | ||||
Cytoplasmic granule | Granzyme A, Granzyme B, Perforin | ||||
Cell signaling protein | STAT, ERK, NFkB Check our cell signalling antibodies | ||||
Proliferation marker | Ki67, PCNA, Bcl-6 | ||||
Adhesion molecule | CD11a, CD58, CD99 | ||||
Migration molecule | CCR4, CCR5, CCR6, CXCR3, CXCR4, CD197, CXCR5, CCR10 | ||||
SARS-CoV2 reactive protein | Neuropilin-1 |
Get more information on what REAfinity Recombinant Antibody means
Read on how researcher trust on our REAfinity Recombinant Antibodies for immune cell characterization in COVID 19 infection.
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.